Opella currently relies on three Egyptian manufacturing partners, with around 90% of its products now produced locally. Telfast, the allergy brand, remains the top revenue driver for Opella Egypt, holding an 18.2% market share and ranking as the number one allergy brand in the country. Regarding exports, the company noted that while regional export potential exists, its near-term focus remains on the local market. “We believe growth starts with bold opportunity,” El Kamhawy added. Impact of Sanofi separationAddressing the recent separation from Sanofi, El Kamhawy described the move as a transformational step that has brought greater agility and autonomy to Opella Egypt.

Source: Daily News Egypt April 10, 2026 11:46 UTC